Laboratory Studies

The following laboratory studies may be included in the workup:

Creatinine level
Complete blood cell count
Liver function tests

Imaging Studies

The workup may include the following imaging studies:

Computed tomography (CT) or MRI scan of the abdomen and pelvis
Chest radiography
Chest CT scanning if the stage is T2 or greater
Bone scanning

Treatment & Management

Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Meretyk S, Darcy MD, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991 Aug. 146(2):278-82. [QxMD MEDLINE Link].
Nadu A, Ekstein P, Szold A, Friedman A, Nakache R, Cohen Y, et al. Ventilatory and hemodynamic changes during retroperitoneal and transperitoneal laparoscopic nephrectomy: a prospective real-time comparison. J Urol. 2005 Sep. 174(3):1013-7. [QxMD MEDLINE Link].
Bishoff JT, Allaf ME, Kirkels W, Moore RG, Kavoussi LR, Schroder F. Laparoscopic bowel injury: incidence and clinical presentation. J Urol. 1999 Mar. 161(3):887-90. [QxMD MEDLINE Link].
Berger AD, Kanofsky JA, O'Malley RL, Hyams ES, Chang C, Taneja SS, et al. Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses. Urology. 2008 Mar. 71(3):421-4. [QxMD MEDLINE Link].
Ouellet S, Carmel M, Martel A, Sabbagh R. Perioperative outcomes for laparoscopic radical nephrectomies performed on ≥ 10 cm tumors. Can J Urol. 2014 Oct. 21 (5):7487-95. [QxMD MEDLINE Link].
Nagele U, Walcher U, Herrmann TR. Initial experience with laparoscopic single-incision triangulated umbilical surgery (SITUS) in simple and radical nephrectomy. World J Urol. 2011 Apr 2. [QxMD MEDLINE Link].
Mucksavage P, McDougall EM, Clayman RV. Laparoscopic transperitoneal nephrectomy for renal cancer: the University of California, Irvine, technique. J Endourol. 2011 Feb. 25(2):195-200. [QxMD MEDLINE Link].
Ha US, Hwang TK, Kim YJ, Oh TH, Jeon YS, Lee W, et al. Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clear-cell renal cell carcinoma: a multi-institutional study. BJU Int. 2011 May. 107(9):1467-72. [QxMD MEDLINE Link].
Sagalowsky AI, Kadesky KT, Ewalt DM, Kennedy TJ. Factors influencing adrenal metastasis in renal cell carcinoma. J Urol. 1994 May. 151(5):1181-4. [QxMD MEDLINE Link].
Hammond L, Powell TM, Schwartz BF. Pure laparoscopic radical nephrectomy for stage T(3b) renal-cell carcinoma: more than 2-year follow-up. J Endourol. 2007 Apr. 21(4):408-10. [QxMD MEDLINE Link].
Steinnerd LE, Vardi IY, Bhayani SB. Laparoscopic radical nephrectomy for renal carcinoma with known level I renal vein tumor thrombus. Urology. 2007 Apr. 69(4):662-5. [QxMD MEDLINE Link].
Yanai Y, Takeda T, Miyajima A, et al. Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery?. Asian J Endosc Surg. 2019 Oct. 12 (4):429-33. [QxMD MEDLINE Link].
Leonardo C, Guaglianone S, De Carli P, Pompeo V, Forastiere E, Gallucci M. Laparoscopic nephrectomy using Ligasure system: preliminary experience. J Endourol. 2005 Oct. 19(8):976-8. [QxMD MEDLINE Link].
Kouba E, Smith AM, Derksen JE, Gunn K, Wallen E, Pruthi RS. Efficacy and safety of en bloc ligation of renal hilum during laparoscopic nephrectomy. Urology. 2007 Feb. 69(2):226-9. [QxMD MEDLINE Link].
Tisdale BE, Kapoor A, Hussain A, Piercey K, Whelan JP. Intact specimen extraction in laparoscopic nephrectomy procedures: Pfannenstiel versus expanded port site incisions. Urology. 2007 Feb. 69(2):241-4. [QxMD MEDLINE Link].
Varkarakis I, Rha K, Hernandez F, Kavoussi LR, Jarrett TW. Laparoscopic specimen extraction: morcellation. BJU Int. 2005 Mar. 95 Suppl 2:27-31. [QxMD MEDLINE Link].
Pareek G, Hedican SP, Gee JR, Bruskewitz RC, Nakada SY. Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques. J Urol. 2006 Apr. 175(4):1208-13. [QxMD MEDLINE Link].
Biggs G, Hafron J, Feliciano J, Hoenig DM. Treatment of splenic injury during laparoscopic nephrectomy with BioGlue, a surgical adhesive. Urology. 2005 Oct. 66(4):882. [QxMD MEDLINE Link].
Cadeddu JA, Ono Y, Clayman RV, Barrett PH, Janetschek G, Fentie DD, et al. Laparoscopic nephrectomy for renal cell cancer: evaluation of efficacy and safety: a multicenter experience. Urology. 1998 Nov. 52(5):773-7. [QxMD MEDLINE Link].
Dunn MD, Portis AJ, Shalhav AL, Elbahnasy AM, Heidorn C, McDougall EM, et al. Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol. 2000 Oct. 164(4):1153-9. [QxMD MEDLINE Link].
Gill IS, Kavoussi LR, Clayman RV, Ehrlich R, Evans R, Fuchs G, et al. Complications of laparoscopic nephrectomy in 185 patients: a multi-institutional review. J Urol. 1995 Aug. 154(2 Pt 1):479-83. [QxMD MEDLINE Link].
Ono Y, Kinukawa T, Hattori R, Yamada S, Nishiyama N, Mizutani K, et al. Laparoscopic radical nephrectomy for renal cell carcinoma: a five-year experience. Urology. 1999 Feb. 53(2):280-6. [QxMD MEDLINE Link].
Barrett PH, Fentie DD, Taranger LA. Laparoscopic radical nephrectomy with morcellation for renal cell carcinoma: the Saskatoon experience. Urology. 1998 Jul. 52(1):23-8. [QxMD MEDLINE Link].
Portis AJ, Yan Y, Landman J, Chen C, Barrett PH, Fentie DD, et al. Long-term followup after laparoscopic radical nephrectomy. J Urol. 2002 Mar. 167(3):1257-62. [QxMD MEDLINE Link].
Bouty A, Burnand K, Nightingale M, Roberts A, Campbell M, O'Brien M, et al. What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature. J Pediatr Urol. 2018 Aug. 14 (4):327.e1-327.e7. [QxMD MEDLINE Link].
Mouraviev V, Nosnik I, Robertson C, Albala D, Walther P, Polascik TJ. Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. Eur Urol. 2007 Mar. 51(3):715-20; discussion 720-1. [QxMD MEDLINE Link].
Guazzoni G, Cestari A, Naspro R, Riva M, Rigatti P. Cost containment in laparoscopic radical nephrectomy: feasibility and advantages over open radical nephrectomy. J Endourol. 2006 Jul. 20(7):509-13. [QxMD MEDLINE Link].
Hollingsworth JM, Miller DC, Dunn RL, Montgomery JS, Wolf JS Jr. Cost trends for oncological renal surgery: support for a laparoscopic standard of care. J Urol. 2006 Sep. 176(3):1097-101; discussion 1101. [QxMD MEDLINE Link].
Desai MM, Gill IS, Ramani AP, Matin SF, Kaouk JH, Campero JM. Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol. 2003 Feb. 169(2):487-91. [QxMD MEDLINE Link].
Gill IS, McClennan BL, Kerbl K, Carbone JM, Wick M, Clayman RV. Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. J Urol. 1994 Oct. 152(4):1082-5. [QxMD MEDLINE Link].
Gill IS, Schweizer D, Hobart MG, Sung GT, Klein EA, Novick AC. Retroperitoneal laparoscopic radical nephrectomy: the Cleveland clinic experience. J Urol. 2000 Jun. 163(6):1665-70. [QxMD MEDLINE Link].
Kapoor A, Nguan C, Al-Shaiji TF, Hussain A, Fazio L, Al Omar M, et al. Laparoscopic management of advanced renal cell carcinoma with level I renal vein thrombus. Urology. 2006 Sep. 68(3):514-7. [QxMD MEDLINE Link].
Kavoussi LR, Kerbl K, Capelouto CC, McDougall EM, Clayman RV. Laparoscopic nephrectomy for renal neoplasms. Urology. 1993 Nov. 42(5):603-9. [QxMD MEDLINE Link].
Kletscher BA, Qian J, Bostwick DG, Blute ML, Zincke H. Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. J Urol. 1996 Jun. 155(6):1844-6. [QxMD MEDLINE Link].
Leonardo C, Guaglianone S, De Carli P, Pompeo V, Forastiere E, Gallucci M. Laparoscopic nephrectomy using Ligasure system: preliminary experience. J Endourol. 2005 Oct. 19(8):976-8. [QxMD MEDLINE Link].
O'Brien WM, Lynch JH. Adrenal metastases by renal cell carcinoma. Incidence at nephrectomy. Urology. 1987 Jun. 29(6):605-7. [QxMD MEDLINE Link].
Rapp DE, Orvieto MA, Gerber GS, Johnston WK 3rd, Wolf JS Jr, Shalhav AL. En bloc stapling of renal hilum during laparoscopic nephrectomy and nephroureterectomy. Urology. 2004 Oct. 64(4):655-9. [QxMD MEDLINE Link].
Schweizer DK, Gill IS, Vorce CL. Financial cost analysis of laparoscopic vs. open radical nephrectomy. J Urol. 2000. 161(4S):11.
Shekarriz B, Meng MV, Lu HF, Yamada H, Duh QY, Stoller ML. Laparoscopic nephrectomy for inflammatory renal conditions. J Urol. 2001 Dec. 166(6):2091-4. [QxMD MEDLINE Link].
Shvarts O, Lam JS, Kim HL, Belldegrun AS. Staging of renal cell carcinoma: current concepts. BJU Int. 2005 Mar. 95 Suppl 2:8-13. [QxMD MEDLINE Link].
Sokolov LK, Nikiforov PA, Bivol NK, Teremkov VK, Gur'ev PV. [Colonoscopy in the diagnosis and follow-up of colonic polyps]. Klin Med (Mosk). 1990 Jun. 68(6):106-10. [QxMD MEDLINE Link].
Walther MM, Lyne JC, Libutti SK, Linehan WM. Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study. Urology. 1999 Mar. 53(3):496-501. [QxMD MEDLINE Link].
Winter P, Miersch WD, Vogel J, Jaeger N. On the necessity of adrenal extirpation combined with radical nephrectomy. J Urol. 1990 Oct. 144(4):842-3; discussion 844. [QxMD MEDLINE Link].

Media Gallery

Trocar placement for a left laparoscopic radical nephrectomy (LRN).
Trocar placement for a right laparoscopic radical nephrectomy (LRN).
Colon mobilization for a right laparoscopic radical nephrectomy (LRN).
Right ureteral dissection using a suction aspirator.
Transection of right renal artery with the endovascular stapler.
Kidney is entrapped in a sack and is then morcellated with ring forceps.

of 6

Author

William J Harmon, MD Medical Director, Urology San Antonio, PAAssociate Clinical Professor, Division of Urology, UTHSC, San Antonio, TX

William J Harmon, MD is a member of the following medical societies: American Urological Association, Phi Beta Kappa

Disclosure: Received honoraria from Pacira Pharmacal for speaking and teaching.

Coauthor(s)

Robert P Caruso, MD Director of Robotic and Laparoscopic Urologic Surgery, Essex-Hudson Urology PC

Robert P Caruso, MD is a member of the following medical societies: Alpha Omega Alpha, American Urological Association, Phi Beta Kappa

Disclosure: Nothing to disclose.

Jay T Bishoff, MD Chairman, Department of Urology, Intermountain Health Care; Director, Intermountain Urological Institute; Vice Chairman, Department of Surgery, Intermountain Medical Center; Associate Clinical Professor of Surgery, University of Utah College of Medicine

Jay T Bishoff, MD is a member of the following medical societies: American College of Surgeons, American Urological Association, Endourological Society

Disclosure: Received honoraria from Pfizer for speaking and teaching; Received none from PerSys for consulting.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Bradley Fields Schwartz, DO, FACS Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, Society of University Urologists

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Endourological Society Board of Directors; President Elect North Central Section of the American Urological Association<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cook Medical.

Acknowledgements

Dan Theodorescu, MD, PhD Paul A Bunn Professor of Cancer Research, Professor of Surgery and Pharmacology, Director, University of Colorado Comprehensive Cancer Center

Dan Theodorescu, MD, PhD is a member of the following medical societies: American Cancer Society, American College of Surgeons, American Urological Association, Medical Society of Virginia, Society for Basic Urologic Research, and Society of Urologic Oncology

Disclosure: Key Genomics Ownership interest Co-Founder-50% Stock Ownership; KromaTiD, Inc Stock Options Board membership